Exports of medical cannabis by volume and destination

​Request ​785892594

Provide a breakdown of exports of medical cannabis from Jersey by volume and destination country (including the UK) from January 2023 to December 2025. Please also break it down by month or quarter.

Response

The attached tables detail the annual export figures for cannabis flower and cannabis oil, by destination (grouped to geographical area; Great Britain and Northern Ireland (N.I.), Europe, and ‘Other’ for all other destinations) for the years 2024 and 2025. Records are not available for 2023. Article 3 of the Freedom of Information (Jersey) Law 2011 therefore applies.

[LINK Export destinations, 2024 to 2025]​

A breakdown of all exports by month or quarter cannot be provided, as it is considered that commercially sensitive information could be discerned from this data (directly, and indirectly in conjunction with other publicly available information). It is also considered that to provide country-specific export destination data could impact commercial interests of those involved in export / import, and present increased risk to security and law enforcement. Therefore, Articles 33 and 42 of the Freedom of Information (Jersey) Law 2011 have been applied.

Articles applied

Article 3 Meaning of “information held by a public authority” 

For the purposes of this Law, information is held by a public authority if – 

(a) it is held by the authority, otherwise than on behalf of another person; or 

(b) it is held by another person on behalf of the authority. 

Article 33 Commercial interests 

Information is qualified exempt information if – 

(a) it constitutes a trade secret; or 

(b) its disclosure would, or would be likely to, prejudice the commercial interests of a person (including the scheduled public authority holding the information).

Article 42 Law enforcement 

Information is qualified exempt information if its disclosure would, or would be likely to, prejudice – 

(a) the prevention, detection or investigation of crime, whether in Jersey or elsewhere

Prejudice / Public Interest Test

Articles 33 and 42 are prejudiced-based qualified exemptions and, as such, Health and Care Jersey (HCJ) has conducted a prejudice and public interest test, as required by law.

HCJ has assessed whether, in all the circumstances of the case, the public interest in supplying the information is outweighed by the prejudice that would likely result by doing so.

• ​​In Jersey’s context, the number of licensed cannabis exporters is small. A breakdown of export volumes by destination country is, therefore, highly likely to enable identification of individual operators’ commercial activity, which would be likely to prejudice the commercial interests of those operators and could compromise the protection of sensitive regulatory information.

• Cannabis exports fall within Jersey’s international controlled drugs framework, with compliance oversight linked to the U.K. parent regulator (the U.K. Home Office), and reporting obligations under the international conventions.​

• Disclosure of detailed export flows could reasonably be expected to create a diversion or security risk by exposing sensitive operational patterns.

It is recognised that there is a public interest in transparency. However, having considered the public interest, HCJ has concluded that the public interest in disclosing this information is outweighed by the potential prejudice that would likely result.